Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 77Brain Neoplasms 75Glioma 68Astrocytoma 30Central Nervous System Neoplasms 24Gliosarcoma 21Neuroblastoma 19Lung Neoplasms 19Ependymoma 19Medulloblastoma 18Oligodendroglioma 17Meningioma 16Breast Neoplasms 15Neoplasm Metastasis 12Carcinoma, Non-Small-Cell Lung 10Sarcoma 7Neuroendocrine Tumors 7Neuroectodermal Tumors, Primitive, Peripheral 7Melanoma 7Glioma, Subependymal 7Ganglioneuroblastoma 7Wilms Tumor 6Thyroid Neoplasms 6Rhabdoid Tumor 6Osteosarcoma 6Neuroectodermal Tumors, Primitive 6Meningeal Carcinomatosis 6Lymphoma, Non-Hodgkin 6Lymphoma 6Histiocytosis, Langerhans-Cell 6

Interventions

Specimen Handling 1Mental Status and Dementia Tests 1Memantine 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Carcinoma × Magnetic Resonance Spectroscopy × CNS × Clear all
NCT04939597 2025-12-22

A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor

Children's Oncology Group

Phase 3 Active not recruiting
192 enrolled
CNS

Central Nervous System Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡